Skip to main content
Emergent BioSolutions Inc. logo

Emergent BioSolutions Inc. — Investor Relations & Filings

Ticker · EBS ISIN · US29089Q1058 LEI · 549300YW6TUOX8BE5103 US Manufacturing
Open in API
Filings indexed 1,264 across all filing types
Latest filing 2015-06-17 Director's Dealing
Country US United States of America
Listing US EBS

About Emergent BioSolutions Inc.

https://emergentbiosolutions.com/

Emergent BioSolutions Inc. is a life sciences company specializing in solutions for public health threats. The company develops, manufactures, and delivers medical countermeasures for national security and public health preparedness, addressing threats such as anthrax, smallpox, botulism, and Ebola. In addition to its biodefense portfolio, Emergent provides commercial products for endemic health crises, notably the opioid epidemic. The company also offers contract development and manufacturing services through strategic partnerships, leveraging its specialized capabilities to support biopharmaceutical innovators, governments, and non-governmental organizations.

Recent filings

Filing Released Lang Actions
FORM 4
Director's Dealing
2015-06-17 English
FORM 4 SUBMISSION
Director's Dealing
2015-06-15 English
FORM 4
Director's Dealing
2015-06-02 English
FORM 4
Director's Dealing
2015-05-28 English
Capital/Financing Update 2015
Capital/Financing Update Classification · 95% confidence The document is a Form S-3 registration statement filed with the SEC by Emergent BioSolutions Inc. It is a registration statement under the Securities Act of 1933 for the purpose of registering securities for sale. The document includes a prospectus describing the general terms of securities to be offered from time to time, including debt securities, common stock, preferred stock, depositary shares, purchase contracts, purchase units, and warrants. It is not a financial report, earnings release, or management discussion. It is a capital markets filing related to fundraising and securities issuance. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is substantial (15,000 characters), and it is not merely an announcement or certification, so it is not RPA or RNS. Hence, the correct classification is CAP with high confidence.
2015-05-22 English
Declaration of Voting Results & Voting Rights Announcements 2015
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a Form 8-K current report filed with the SEC, dated May 21, 2015. It includes announcements about the appointment of a director to board committees and detailed voting results from the 2015 annual meeting of stockholders. The presence of voting results from the shareholder meeting indicates this is a Declaration of Voting Results & Voting Rights Announcement. The document length is 4076 characters, which is relatively short and focused on voting outcomes rather than full financial or management reports. Therefore, the appropriate classification is DVA (Declaration of Voting Results & Voting Rights Announcements).
2015-05-21 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.